Kirsten L. White

Gilead Sciences Inc., USA

Kirsten Lofgren White, Ph.S. 2001 Ph.D. in Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 1993 B.S. in Microbiology, B.A. in Psychology, University of California, San Diego, California Senior Research Scientist II, Clinical Virology, Gilead Sciences, Inc., Foster City, CA (Mar. 2001-present) • Responder for Virology at the FDA Advisory Committee Meeting for QUAD for HIV • Nonclinical and Clinical Resistance lead for the US and EU filing of the HIV-1 single tablet regimens Complera and QUAD • Lead interdepartmental teams and academic collaborations to define the biochemical mechanisms of resistance of HIV-1 reverse transcriptase to NRTIs to support Viread and Emtriva programs • Managed Research Associates and a Research Scientist • Development team member, research sub-team and clinical sub-team member; responsible for virology resistance analyses studies (internal and contracted research) and mechanism of action studies to support the IND and NDA for HIV-1 antivirals • Developed virology substudy protocols, managed contract lab studies, monitored viral rebound and resistance development, and is responsible for resistance analyses for US and international HIV-1 clinical trials (pediatric, adolescent, and adult populations) • Provided regulatory support for US IND and NDA and EMEA annual reports for the HIV-1 drugs Atripla, Truvada, and Viread • Support drug discovery for the evaluation of inhibitors against viral polymerases, including HIV-1 reverse transcriptase and HCV NS5B polymerase by developing assays used for screening and mechanism of action studies • Presented lectures and seminars at scientific meetings, internally, and Universities and published in peer-reviewed journals

Biography Updated on 18 May 2012

Scholarly Contributions [Data Provided by ]